Related Experiment Videos
Use less cosmetics--suffer less from fibromyalgia?
1Department of Rheumatology, Mälarsjukhuset, 631-88 Eskilstuna, Sweden. berit.sverdrup@mse.dll.se
Journal of Women'S Health (2002)
|April 10, 2004
Summary
Reducing cosmetic use significantly improved fibromyalgia symptoms, including pain, sleep, and fatigue. This suggests a potential link between cosmetic products and fibromyalgia syndrome (FMS) symptom severity.
Area of Science:
- Rheumatology
- Dermatology
- Clinical Medicine
Background:
- Fibromyalgia syndrome (FMS) is characterized by widespread pain, fatigue, and sleep disturbances, primarily affecting women.
- The exact cause of FMS remains unknown, with patients often presenting with normal physical appearance but exhibiting tender points.
- A clinical observation suggested a correlation between dry skin, cosmetic use, and FMS symptoms.
Purpose of the Study:
- To investigate the hypothesis that reduced cosmetic use could alleviate symptoms in women with fibromyalgia syndrome (FMS).
- To assess the impact of a modified skincare and reduced cosmetic regimen on FMS patient outcomes.
Main Methods:
- A prospective, randomized, controlled trial involving 48 women diagnosed with FMS.
- Participants were regular users of cosmetics; the intervention group received specific skin care instructions and reduced cosmetic use.
- Outcomes were measured using the Fibromyalgia Impact Questionnaire (FIQ) over a 2-year period.
Main Results:
- The experimental group showed statistically significant improvements in pain (p < 0.02), sleep quality (p < 0.01), and stiffness (p < 0.02).
- Significant enhancements were also observed in physical function (p < 0.01) and overall wellbeing (p < 0.01) within the intervention group.
- These improvements were sustained over the 2-year study duration.
Conclusions:
- Reduced cosmetic use may be a beneficial intervention for managing fibromyalgia symptoms.
- The findings warrant further research into the potential adverse effects of cosmetic products on FMS and other conditions.
- This study highlights a novel therapeutic avenue for fibromyalgia management.